Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 22 Observational 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 7 Pancreatic Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Rectal Neoplasms 1 Pseudomyxoma Peritonei 1 Peritoneal Neoplasms 1 Neutropenia 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Muscle Neoplasms 1 Mesothelioma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Liver Neoplasms 1 Keratosis, Actinic 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Chronic Pain 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Breast Cancer Organoids 1

Interventions

3-ingenyl angelate 5 Imiquimod 4 methyl 5-aminolevulinate 2 Tomography, Optical Coherence 2 tirbanibulin 1 Surveys and Questionnaires 1 Solutions 1 Microarray Analysis 1 Fluorouracil 1 Diclofenac 1 Biopsy 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Keratosis, Actinic × Fluorouracil × Clear all

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡